Quality Assurance Project in Patients With Advanced Prostate Carcinoma - Evaluation of Tolerability, Quality of Life and Usage of Zoladex 10,8 SafeSystem
N/A
N/A
N/A
N/A
N/A
Not Enrolling
Male
Prostate Carcinoma
Male
Prostate Carcinoma
Trial Information
Quality Assurance Project in Patients With Advanced Prostate Carcinoma - Evaluation of Tolerability, Quality of Life and Usage of Zoladex 10,8 SafeSystem
Inclusion Criteria:
- Patients with PCa, who will be treated with Zoladex 10,8 SafeSystem based on the
current SPC
Type of Study:
Observational
Study Design:
Observational Model: Defined Population, Observational Model: Natural History, Time Perspective: Longitudinal, Time Perspective: Prospective
Principal Investigator
H Brasch
Investigator Role:
Study Director
Investigator Affiliation:
AstraZeneca
Authority:
Germany: Federal Institute for Drugs and Medical Devices
Study ID:
Zx-002
NCT ID:
NCT00540059
Start Date:
June 2005
Completion Date:
Related Keywords:
- Prostate Carcinoma
- Prostate carcinoma
- LHRH
- Zoladex
- Carcinoma
- Prostatic Neoplasms
Name | Location |
|---|
